U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                   Form 10-QSB


(Mark One)
[ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
      OF THE SECURITIES EXCHANGE ACT OF 1934

                       For the quarter ended May 31, 1997

                                       OR

[   ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
      OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________________ to __________________


                         Commission File No. 2-88678-NY

                          MEDI-DATA INTERNATIONAL, INC.
--------------------------------------------------------------------------------
                 (Name of small business issuer in its charter)

     New York                                         11-2653474
--------------------------------------------------------------------------------
(State or other jurisdiction                       (I.R.S. Employer 
of incorporation)                                  Identification No.)

                20 Red Ground Road, Old Westbury, New York 11568
--------------------------------------------------------------------------------
                    (Address of principal executive offices)

                    Issuer's telephone number: (516) 626-0360
--------------------------------------------------------------------------------
       Securities registered under Section 12(b) of the Exchange Act: None
         Securities registered under Section 12(g) of the Exchange Act:

                         Common Stock, $0.001 Par Value
                                (Title of Class)

     Check  whether  the issuer (1) filed all  reports  required  to be filed by
section 13 or 15(d) of the  Exchange  Act during the past 12 months (or for such
shorter period that the  registrant was required to file such reports),  and (2)
has been subject to such filing requirements for the past 90 days.
Yes [ X ]    No [    ]


 Number of shares outstanding of the issuer's common equity, as of July 7, 1997
      (exclusive of securities convertible into common equity) : 9,212,551
<PAGE>
                                     Part I


Item 1.  Business Development

In  April  1988,  Medi-Data  International,  Inc.  (the  "Company")  ceased  all
operations.  When it was  operating,  the Company  had  devoted its  business to
developing  a program  to monitor  the  interaction  and misuse of  prescription
drugs,  over-the-counter medication and food supplements. For the quarters ended
May 31, 1997 and 1996, the Company had no operations or income from operations.

During the year ended  February 29,  1996,  the Company  invested in  marketable
securities which resulted in realized gains of $74,004. At February 29, 1996 all
of the marketable securities have been sold.

The  company is  presently  seeking to acquire an  operating  company for stock.
There are no  present  agreements  or  understandings  with  respect  to such an
acquisition  nor can there be any  assurance  that the  Company can make such an
acquisition in the near future.

Item 2.  Properties

The Company does not lease or own any properties.

Item 3.  Legal Proceedings

To the Company's  knowledge,  there is no legal proceeding  pending to which the
Company is a party or to which any of their properties is subject.

Item 4.  Submission of Matters to a Vote of Security Holders

Not Applicable.
<PAGE>
                                     Part II

Item 5.  Market For Common Equity and Related Stockholder Matters.

The Company has paid no  dividends,  either in cash or in stock.  It is unlikely
that the Company will pay any dividends as it has ceased  operations as of April
1988.

Item 6. Management's  Discussion and Analysis of Financial Condition and Results
of Operations.

Results of Operations

For the quarters ended May 31, 1997,  and 1996 the Company had no activity.  For
the year  ended  February  28,  1997 the  Company  had a net loss of  $1,995  as
compared  to a net income of $2,665 for the year ended  February  29,  1996.  In
1995, the Company invested in marketable securities which resulted in a realized
gain for the year  ended  February  29,  1996 of  $74,004.  The  Company  had no
investements in securities for the current year.

Liquidity and Capital Resources

The Company  ceased all previous  operations in April 1988, and for the quarters
ended  May 31,  1997 and 1996 the  company  had no  operations  or  income  from
operations.  During the quarter  ended  August 31, 1995 the Company  invested in
marketable securities and the proceeds were used to pay the shareholder loans in
full. All securities  were sold by the fiscal year end of February 1996, and the
Company  has not made any  additional  investments.  At May 31,1997 and 1996 the
Company  has  a   shareholders'   deficiency   of  $1,059,567   and   $1,057,572
respectively.

Item 7. Financial Statements.

The Company's financial statements are set forth herein.

Item  8.  Changes  in and  Disagreements  with  Accountants  on  Accounting  and
Financial Disclosure.

No disagreements or changes occurred.



















                                       -2-
<PAGE>
<TABLE>
<CAPTION>
                                     MEDI-DATA INTERNATIONAL, INC.
                                            BALANCE SHEETS

                                                                           Unaudited
                                                                            May 31         February 28
                                                                             1997             1997
                                                                         -----------      -----------
 
                  ASSETS
<S>                                                                      <C>              <C>
CURRENT ASSETS
         Cash, including money market funds of $63 .................     $        66      $       128
         Due from shareholder ......................................           5,650            5,650
                                                                         -----------      -----------

                  TOTAL ASSETS .....................................     $     5,716      $     5,778
                                                                         ===========      ===========

                  LIABILITIES AND SHAREHOLDERS' DEFICIENCY IN ASSETS


CURRENT LIABILITIES
         Due to shareholders .......................................     $       400      $       400
         Accrued expenses and other current liabilities ............          61,716           61,778
                                                                         -----------      -----------

                  Total Current Liabilities ........................          62.116           62,178
                                                                         -----------      -----------

COMMITMENTS AND CONTINGENCIES

SHAREHOLDERS' DEFICIENCY IN ASSETS
         Common stock, $.001 par value 50,000,000 shares authorized,
           9,213,051 issued and outstanding ........................           9,213            9,213
         Additional paid-in capital ................................         993,954          993,954
         Accumulated Deficit .......................................      (1,059,567)      (1,059,567)
                                                                         -----------      -----------
                  Total Shareholders' Deficiency in Assets .........         (56,400)         (56,400)
                                                                         -----------      -----------

                  TOTAL LIABILITIES AND
                    SHAREHOLDERS' DEFICIENCY IN ASSETS .............     $     5,716      $     5,778
                                                                         ===========      ===========




                            See accompanying notes to financial statements 
 
</TABLE>







                                       -3-
<PAGE>
<TABLE>
<CAPTION>
                                MEDI-DATA INTERNATIONAL, INC.
                              UNAUDITED STATEMENT OF OPERATIONS
                                FOR THE QUARTERS ENDED MAY 31,


                                                                    1997            1996
                                                                -----------      -----------
<S>                                                             <C>              <C>
  Costs & Expenses:
         Selling, general and administrative expenses .....     $         0      $         0
                                                                -----------      -----------
         Loss before other income and state income taxes ..               0                0
                                                                -----------      -----------

Other Income (Expenses):
         Interest and dividend income .....................               0                0
                                                                -----------      -----------
                  Total Other Income (Expense) ............               0                0

              Income (Loss) before state income taxes .....               0                0

              State income taxes ..........................               0                0
                                                                -----------      -----------

                  Net Income (Loss) .......................               0                0
                                                                ===========      ===========

              Accumulated Deficit - beginning .............      (1,059,567)      (1,057,572)
                                                                -----------      -----------

              Accumulated Deficit- end ....................     $(1,059,567)     $(1,057,572)
                                                                ===========      ===========



              Earnings per share ..........................     $     0.000      $    0.0000
                                                                ===========      ===========


              Primary and Fully Diluted shares ............       9,212,551        9,212,551
                                                                ===========      ===========





                        See accompanying notes to financial statements  

</TABLE>






                                             -4-

<PAGE>
<TABLE>
<CAPTION>
                          MEDI-DATA INTERNATIONAL, INC.
                       UNAUDITED STATEMENTS OF CASH FLOWS
                          FOR THE QUARTER ENDED MAY 31,


                                                                 1997       1996
                                                                -----      -----
<S>                                                             <C>        <C>
Cash flows from operating activities ......................         0          0
                                                                -----      -----
          Net Income (Loss)

          Adjustments to reconcile net income to net cash
              provided by (used in) operating activities

         (Increase) Decrease In:

         Prepaid Income Taxes .............................         0       (293)

         Increase (decrease) in:

         Accrued expenses and other current liabilities ...       (62)      (489)
                                                                -----      -----
              Net cash used in operating activities .......       (62)      (782)

              Net increase(decrease) in cash and equivalent       (62)      (782)

              Cash and cash equivalents - beginning .......       128        845
                                                                -----      -----

              Cash and cash equivalents - end .............     $  66      $  63
                                                                =====      =====

<CAPTION>


                       SUPPLEMENTAL CASH FLOW INFORMATION 

          Cash paid for interest and taxes was as follows:     1997        1996
                                                               ----        ----
<S>                                                            <C>         <C>
                      Interest                                  -           -

                      Taxes                                    388         -0-



                 See accompanying notes to financial statements 
</TABLE>




                                      -5-
<PAGE>
                          MEDI-DATA INTERNATIONAL, INC.
                          NOTES TO FINANCIAL STATEMENTS
                  FOR THE QUARTERS ENDED MAY 31, 1997 AND 1996



         1        SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

                      BASIS OF PRESENTATION

                  The Company is not actively  engaged in any trade or business.
                  The  financial  statements  of the Company are  presented on a
                  condensed   basis.   In  the   opinion  of   management,   the
                  accompanying  unaudited financial information contains all the
                  necessary adjustments to fairly present the financial position
                  of the  Company as of May 31,1997 and 1996 and for the periods
                  then ended.


                  PER SHARE DATA

                  Loss per  share is based on the  weighted  average  number  of
                  shares of common stock outstanding during each period.



































                                      -6-
<PAGE>
                                    Part III


Item 9. Directors,  Executive Officers, Promoters and Control Person; Compliance
with Section 16(a) of the exchange act.

The following  table sets forth  information  as of July 7, 1997 with respect to
the officers and directors of the Company:
<TABLE>
<CAPTION>

                                           Year First Appointed
 Name                             Age           Director             Office Held
 ----                             ---           --------             -----------
<S>                               <C>            <C>                  <C>
Terry Brooks                      44             1994                 President
Gary Nadelman                     45             1996                 Secretary
</TABLE>

The term of office of each of the above  directors,  pursuant  to the By-laws of
the Company,  will continue  until the next Annual Meeting of  Shareholders  and
until their respective successors are elected and qualified.


TERRY BROOKS is President  and a director of the  Company.  Ms.  Brooks has been
President of the company since  September 27, 1994 when Marc Gold resigned.  Ms.
Brooks has served as a director of the Company  since  January 24, 1994 when she
became a principal shareholder of the Company. Ms. Brooks for more than the past
five  years  has  been  principally   engaged  in  management  of  her  personal
investments.


GARY NADELMAN is Secretary and a director of the Company.  Mr. Nadelman has been
the president of Synari Inc., of New York, NY, a privately held  manufacturer of
women's sportswear and other apparel, for more than five years.


Item 10.  Executive Compensation.


No officer or director of the Company received compensation as salary during the
quarters ended May 31, 1997 and 1996.

Item  11. Security Ownership of Certain Beneficial Owners and Management.

The following table sets forth the beneficial  ownership of the Company's common
stock as of July 7, 1997 for each person  known by the  Company to  beneficially
own more than five percent of the shares of the outstanding  Common Stock,  each
of the Company's directors, and the executive officers listed in Item 9.









                                      -7-
<PAGE>
<TABLE>
<CAPTION>

      Name of Individual                       No. of Shares             % of Outstanding
      Or Identity of Group                       Owned (1)                 Common Stock
      --------------------                       ---------                 ------------
<S>                                             <C>                             <C>
      Terry Brooks                              5,500,000 (2)                   60%

      Terry Brooks IRA                          2,500,000                       27%

      All Officers and Directors
      as a Group (2 people)                     5,500,000 (2)                   60%

1 - Based on the  information  furnished  by the  beneficial  owners.  Except as
otherwise indicated herein, each beneficial owner has sole voting power and sole
investment power with respect to all shares owned.

2 - Includes  3,000,000  shares held by Ms.  Brooks as  custodian  for her minor
children.
</TABLE>


Item 12.  Certain Relationship and Related Transactions.

                   none
































                                      -8-
<PAGE>




                                   SIGNATURES


Pursuant to the  requirements of Section 13 or 15(d) of the Securities  Exchange
Act of 1934,  the  Registrant  has duly  caused  this report to be signed by the
undersigned, thereunto duly authorized.






Dated:  July 7, 1997                               MEDI DATA INTERNATIONAL, INC.


                                                   /S/ TERRY BROOKS 
                                                   ----------------
                                                   Terry Brooks, President




































                                      -9-